Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Altchem Ltd Insider Profile
4 Followers
Altchem Ltd, Ten Percent Owner at RVL Pharmaceuticals, holds 6.12M shares in RVL Pharmaceuticals (Ticker: RVLPQ). Most recently, Altchem Ltd Sold $14,122,659 shares of RVL Pharmaceuticals on Oct 23, 2023 for an estimated value of 517.32K.
Altchem Ltd has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Ten Percent Owner
Roles that Altchem Ltd holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jan 15, 2020 - Jan 15, 2021
Return:-12.60%
The most profitable trade made by Altchem Ltd
Altchem Ltd's Trading History
List of latest transactions for each holding click on a transaction to see Altchem Ltd's performance on stock
You May Also Like
Altchem Ltd insider profile FAQ
What is the percentage of profitable transactions made by Altchem Ltd?
The percentage of profitable transactions made by Altchem Ltd is ―.
What is the average return per transaction made by Altchem Ltd?
The average return per transaction made by Altchem Ltd is ―.
What stocks does Altchem Ltd hold?
Altchem Ltd holds: RVLPQ stocks.
What was Altchem Ltd’s latest transaction?
Altchem Ltd latest transaction was an Informative Sell of $517.32K.
What was Altchem Ltd's most profitable transaction?
Altchem Ltd’s most profitable transaction was an Informative Buy of RVLPQ stock on January 15, 2020. The return on the trade was -12.60%.
What is Altchem Ltd's role in RVL Pharmaceuticals?
Altchem Ltd's role in RVL Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.